Search

Neural diseases are challenging to treat and are regarded as one of the major causes of disability and morbidity in the world. Stem cells can provide a solution, by offering a mechanism to replace damaged circuitry. However, obtaining sufficient cell sources for neural regeneration remains a significant challenge. In recent years, waste-derived stem(-like) cells (WDS-lCs) extracted from both prenatal and adult clinical waste tissues/products, have gained increasing attention for application in neural tissue repair and remodeling. This often-overlooked pool of cells possesses favorable characteristics; including self-renewal, neural differentiation, secretion of neurogenic factors, cost-effectiveness, and low ethical concerns. Here, we offer a perspective regarding the biological properties, extraction protocols, and preclinical and clinical treatments where prenatal and adult WDS-lCs have been utilized for cell replacement therapy in neural applications, and the challenges involved in optimizing these approaches toward patient led therapies., Competing Interests: The authors declare no financial interest., (© 2024 The Author(s).)

The incorporation of nanotechnology in regenerative medicine is at the nexus of fundamental innovations and early-stage breakthroughs, enabling exciting biomedical advances. One of the most exciting recent developments is the use of nanoscale constructs to influence the fate of cells, which are the basic building blocks of healthy function. Appropriate cell types can be effectively manipulated by direct cell reprogramming; a robust technique to manipulate cellular function and fate, underpinning burgeoning advances in drug delivery systems, regenerative medicine, and disease remodeling. Individual transcription factors, or combinations thereof, can be introduced into cells using both viral and nonviral delivery systems. Existing approaches have inherent limitations. Viral-based tools include issues of viral integration into the genome of the cells, the propensity for uncontrollable silencing, reduced copy potential and cell specificity, and neutralization via the immune response. Current nonviral cell reprogramming tools generally suffer from inferior expression efficiency. Nanomaterials are increasingly being explored to address these challenges and improve the efficacy of both viral and nonviral delivery because of their unique properties such as small size and high surface area. This review presents the state-of-the-art research in cell reprogramming, focused on recent breakthroughs in the deployment of nanomaterials as cell reprogramming delivery tools., (© 2022 The Authors. Advanced Materials published by Wiley-VCH GmbH.)

The aim of this study was to investigate the net effect of raw carbon nanotube (CNTs) on the final properties of polyurethane (PU)/CNT composites considering their biomedical applications. So, neat PU and PU/CNT composites containing different amounts of CNTs (0.05%, 0.1%, 0.5%, and 1%) were prepared by electrospinning. Electrospinning parameters optimized to have a bead-free structure with no significant difference between their mean fiber diameter and porosity percentage. The results showed adding CNTs caused an increase in crystallinity percentage, water absorption ratio, young modulus, toughness, conductivity, degradation time in an accelerated medium, clotting time, and human umbilical vein endothelial cells adhesion. But a direct relationship between CNT percentage and the calcium adsorption was not detected. Moreover, no significant cytotoxicity was observed for 7-day extracts of all samples. These nanocomposites have a vast range of properties which make them a good candidate as neural, cardiovascular, osseous biomaterials or tendon, and ligament substitute., (Copyright © 2020 Elsevier B.V. All rights reserved.)